Omega Fund Management, LLC
CIK: 0001637359SEC EDGAR →
Portfolio Value
$286.5B
Holdings
11
As of
Q4 2025
New Positions
2
Closed Positions
2
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Nuvation Bio | 8,081,089 | $72.4B | 25.27% |
| 2 | BridgeBio Oncology Therapeutics Inc. | 3,289,661 | $41.2B | 14.37% |
| 3 | Beta Bionics Inc. | 1,316,183 | $40.1B | 14.00% |
| 4 | Bicara Therapeutics Inc. | 2,204,650 | $37.1B | 12.95% |
| 5 | Kestra Med Technologies Ltd | 1,373,591 | $36.4B | 12.71% |
| 6 | Upstream Bio Inc. | 1,326,293 | $36.0B | 12.57% |
| 7 | enGene Holdings Inc. | 876,357 | $7.9B | 2.76% |
| 8 | Alumis Inc. | 653,223 | $6.4B | 2.22% |
| 9 | Sana Biotechnology, Inc. | 843,750 | $3.4B | 1.20% |
| 10 | ImageneBio, Inc. | 455,361 | $3.1B | 1.10% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 11 | $286.5B | 100.0% |